Clínic Barcelona
Research

A biomarker in a blood test makes it possible to diagnose Alzheimer’s disease

A study by the hospital Clínic Barcelona-IDIBAPS, published in the journal Neurology, confirms the usefulness of a blood-based biomarker to diagnose Alzheimer’s disease without the need for more invasive and costly tests.

From left to right, Albert Lladó, Raquel Ruiz, Laura Naranjo, Mircea Balasa, Jordi Sarto and Raquel Sánchez-Valle (Hospital Clínic).

From left to right, Albert Lladó, Raquel Ruiz, Laura Naranjo, Mircea Balasa, Jordi Sarto and Raquel Sánchez-Valle (Hospital Clínic).

Keep reading about:

Related news